Filtered By:
Nutrition: Vitamin B12
This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 86 results found since Jan 2013.
The Effect of Metformin on Vitamin B12 Deficiency and Stroke
CONCLUSIONS: T2DM is a significant risk factor to the development of ischemic stroke. We found an association between metformin use and vitamin B12 deficiency and an association between vitamin B12 deficiency and stroke risk in patients with T2DM. Diabetic patients who are taking metformin should monitor their vitamin B12 level.PMID:36841981
Source: The Israel Medical Association Journal - February 26, 2023 Category: General Medicine Authors: Nizar Horrany Wadie Abu Dahoud Yara Moallem Taleb Hajouj Merna Zreik Arnon Blum Source Type: research
A Potential Strategy for Atherosclerosis Prevention in Modernizing China - Hyperhomocysteinemia, MTHFR C677T Polymorphism and Air Pollution (PM2.5) on Atherogenesis in Chinese Adults
CONCLUSION: HC and PM2.5 pollution but not MTHFR genotype were both related to carotid IMT, independent of other traditional risk factors. This has potential implications in dietary and AP strategies for atherosclerosis prevention in China.PMID:36806868 | DOI:10.1007/s12603-023-1889-x
Source: Atherosclerosis - February 22, 2023 Category: Cardiology Authors: C Y T Kwok Y K P Poon P Chook D S Guo C Q Lin Y H Yin D S Celermajer K S Woo Source Type: research
A Potential Strategy for Atherosclerosis Prevention in Modernizing China — Hyperhomocysteinemia, MTHFR C677T Polymorphism and Air Pollution (PM2.5) on Atherogenesis in Chinese Adults
ConclusionHC and PM2.5 pollution but not MTHFR genotype were both related to carotid IMT, independent of other traditional risk factors. This has potential implications in dietary and AP strategies for atherosclerosis prevention in China.
Source: The Journal of Nutrition, Health and Aging - February 3, 2023 Category: Nutrition Source Type: research
Reply for ‘Letter to the Editor’, “B vitamins for NASH: use methylcobalamin, not cyanocobalamin” written by Dr. J. David Spence.
We appreciate the letter by Dr. Spence advocating the use of methylcobalamin or hydroxycobalamin rather than the cyanocoblamin form of vitamin B12 (B12) in future clinical trials investigating the efficacy of B vitamins to prevent or treat NASH. This is similar to the concern that he raised previously for studies that employed B12 in the prevention of stroke 1,2. Although several large trials previously showed no benefit of folate and/or B vitamins (B6 and B12) in reducing cardiovascular events 3, reanalysis of data from one of them (the VISP trial), showed there was a 34% reduction stroke/myocardial infarction events over...
Source: Journal of Hepatology - October 14, 2022 Category: Gastroenterology Authors: Madhulika Tripathi, Brijesh Kumar Singh, Paul M. Yen Tags: Letter to the Editor Source Type: research
Reply to: “B vitamins for NASH: Use methylcobalamin, not cyanocobalamin”
We appreciate the letter by Dr. Spence advocating the use of methylcobalamin or hydroxycobalamin rather than the cyanocobalamin form of vitamin B12 (B12) in future clinical trials investigating the efficacy of B vitamins to prevent or treat NASH.1 This is similar to the concern that he raised previously regarding studies that employed B12 for the prevention of stroke.3,4 Although several large trials previously showed no benefit of folate and/or B vitamins (B6 and B12) in reducing cardiovascular events,4 reanalysis of data from one of them (the VISP trial) showed there was a 34% reduction in stroke/myocardial infarction ev...
Source: Journal of Hepatology - October 14, 2022 Category: Gastroenterology Authors: Madhulika Tripathi, Brijesh Kumar Singh, Paul Michael Yen Tags: Letter to the Editor Source Type: research
Hyperhomocysteinemia in cardiovascular diseases: revisiting observational studies and clinical trials
In conclusion, revisiting observational studies and clinical trials suggests that cardiovascular patients should be screened for hyperhomocysteinemia, when no other risk factor is found. Patients with intermediate/major hyperhomocysteinemia should be properly assessed and treated for vitamin B deficiencies and inherited disorders according to current guidelines. Further trials are needed to assess the lowering homocysteine effect according to hyperhomocysteinemia categories at baseline.PMID:36170884 | DOI:10.1055/a-1952-1946
Source: Thrombosis and Haemostasis - September 28, 2022 Category: Hematology Authors: Jean-Louis Gueant Rosa-Maria Gueant-Rodriguez Abderrahim Oussalah Stephane Zuily Irwin Rosenberg Source Type: research
Thromboembolic complications of recreational nitrous oxide (ab)use: a systematic review
We report on the thromboembolic complications, a less known side effect, associated with recreational inhalation of nitrous oxide. An extensive literature search was performed for publications reporting on the thromboembolic complications associated with recreational nitrous oxide abuse. Data about sex, age, location of thrombosis, laboratory findings, therapy and outcome were collected. A total of 13 case reports or case series were identified comprising a total of 14 patients. The reported thromboembolic side effects included deep venous thrombosis, pulmonary embolism, mesenterial-, portal and splenic vein thrombosis, ce...
Source: Journal of Thrombosis and Thrombolysis - June 27, 2022 Category: Hematology Source Type: research
A Study of Srum Homocysteine Level in Ischaemic Stoke
CONCLUSION: The present study revealed that hyperhomocysteinemia appears to be an important risk factor for ischemic stroke. It is therefore important to use serum homocysteine as an important tool to investigate all cases of ischemic stroke and if serum homocysteine is elevated patient should be put on multivitamins containing vitamin B12, folic acid and pyridoxine to reduce serum homocysteine levels.PMID:35443421
Source: Atherosclerosis - April 21, 2022 Category: Cardiology Authors: Kaushik Paul Ramakrishna Mr Source Type: research
